<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37717009</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA.</ArticleTitle><Pagination><StartPage>5764</StartPage><MedlinePgn>5764</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5764</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-41511-3</ELocationID><Abstract><AbstractText>The expanded hexanucleotide GGGGCC repeat mutation in the C9orf72 gene is the main genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Under one disease mechanism, sense and antisense transcripts of the repeat are predicted to bind various RNA-binding proteins, compromise their function and cause cytotoxicity. Here we identify phenylalanine-tRNA synthetase (FARS) subunit alpha (FARSA) as the main interactor of the CCCCGG antisense repeat RNA in cytosol. The aminoacylation of tRNA<sup>Phe</sup> by FARS is inhibited by antisense RNA, leading to decreased levels of charged tRNA<sup>Phe</sup>. Remarkably, this is associated with global reduction of phenylalanine incorporation in the proteome and decrease in expression of phenylalanine-rich proteins in cellular models and patient tissues. In conclusion, this study reveals functional inhibition of FARSA in the presence of antisense RNA repeats. Compromised aminoacylation of tRNA could lead to impairments in protein synthesis and further contribute to C9orf72 mutation-associated pathology.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Malnar &#x10c;rnigoj</LastName><ForeName>Mirjana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6200-6251</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, 1000, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, Ljubljana, 1000, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>&#x10c;er&#x10d;ek</LastName><ForeName>Ur&#x161;a</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, 1000, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, Ljubljana, 1000, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Xiaoke</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5172-0935</Identifier><AffiliationInfo><Affiliation>King's BHF Centre, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Manh Tin</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Institute of Cell Biology, University of Bern, Bern, 3012, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Repic Lampret</LastName><ForeName>Barbka</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinical Institute of Special Laboratory Diagnostics, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, 1000, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Molecular Neuropathology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, T&#xfc;bingen, 72076, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropathology, University Hospital of T&#xfc;bingen, T&#xfc;bingen, 72076, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology and Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Rostock/Greifswald, 18147, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouleau</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8403-1418</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, QC, H3A 0G4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montr&#xe9;al, QC, H3A 0G4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suter</LastName><ForeName>Beat</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Cell Biology, University of Bern, Bern, 3012, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayr</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0597-829X</Identifier><AffiliationInfo><Affiliation>King's BHF Centre, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogelj</LastName><ForeName>Boris</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3898-1943</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, 1000, Slovenia. boris.rogelj@ijs.si.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, 1000, Slovenia. boris.rogelj@ijs.si.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>47E5O17Y3R</RegistryNumber><NameOfSubstance UI="D010649">Phenylalanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012360">RNA, Transfer, Phe</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016372">RNA, Antisense</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046249" MajorTopicYN="N">Transfer RNA Aminoacylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049148" MajorTopicYN="N">Aminoacylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010649" MajorTopicYN="N">Phenylalanine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012360" MajorTopicYN="N">RNA, Transfer, Phe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016372" MajorTopicYN="N">RNA, Antisense</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>17</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>16</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37717009</ArticleId><ArticleId IdType="pmc">PMC10505166</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-41511-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-41511-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwartz JL, Jones KL, Yeo GW. Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies. Crit. Rev. Biochem. Mol. Biol. 2021;56:31. doi: 10.1080/10409238.2020.1841726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2020.1841726</ArticleId><ArticleId IdType="pmc">PMC8192115</ArticleId><ArticleId IdType="pubmed">33172304</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W, Van Den Bosch L. RNA toxicity in non-coding repeat expansion disorders. EMBO J. 2020;39:e101112. doi: 10.15252/embj.2018101112.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, et al. The C9ORF72 expansion mutation is a common cause of ALS+/&#x2212;FTD in Europe and has a single founder. Eur. J. Hum. Genet. 2012;21:102&#x2013;108. doi: 10.1038/ejhg.2012.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2012.98</ArticleId><ArticleId IdType="pmc">PMC3522204</ArticleId><ArticleId IdType="pubmed">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CA, Lally C, Kupelian V, Dana Flanders W. Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants. Neuroepidemiology. 2021;55:342&#x2013;353. doi: 10.1159/000516752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516752</ArticleId><ArticleId IdType="pubmed">34247168</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Tsuiji H. There has been an awakening: emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res. 2016;1647:19. doi: 10.1016/j.brainres.2016.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.004</ArticleId><ArticleId IdType="pmc">PMC5003651</ArticleId><ArticleId IdType="pubmed">27059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan R, et al. Multifaceted genes in amyotrophic lateral sclerosis-frontotemporal dementia. Front. Neurosci. 2020;14:684. doi: 10.3389/fnins.2020.00684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00684</ArticleId><ArticleId IdType="pmc">PMC7358438</ArticleId><ArticleId IdType="pubmed">32733193</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S, van der Zee J, Cruts M, Van Broeckhoven C. Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 2017;44:117&#x2013;124. doi: 10.1016/j.gde.2017.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.02.008</ArticleId><ArticleId IdType="pubmed">28319737</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat. Rev. Neurosci. 2016;17:383&#x2013;395. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl Acad. Sci. USA. 2013;110:7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA Foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, et al. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 2013;126:845&#x2013;857. doi: 10.1007/s00401-013-1200-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl Acad. Sci. USA. 2013;110:E4968&#x2013;E4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;esnik AB, et al. Nuclear RNA foci from C9ORF72 expansion mutation form paraspeckle-like bodies. J. Cell. Sci. 2019;132:jcs224303. doi: 10.1242/jcs.224303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.224303</ArticleId><ArticleId IdType="pubmed">30745340</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy. Acta Neuropathol. 2015;130:63&#x2013;75. doi: 10.1007/s00401-015-1429-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1429-9</ArticleId><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatovec S, Kovanda A, Rogelj B. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neurobiol. Aging. 2014;35:2421.e1&#x2013;2421.e12. doi: 10.1016/j.neurobiolaging.2014.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.015</ArticleId><ArticleId IdType="pubmed">24836899</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126:385&#x2013;399. doi: 10.1007/s00401-013-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi, S. et al. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 128, 1787&#x2013;99 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue GM, et al. SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat. Commun. 2017;8:1&#x2013;18. doi: 10.1038/ncomms16063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16063</ArticleId><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo&#x17e;i&#x10d;, J. et al. Interactome screening of C9orf72 dipeptide repeats reveals VCP sequestration and functional impairment by polyGA. Brain145, 684&#x2013;699 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9014755</ArticleId><ArticleId IdType="pubmed">34534264</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DA, et al. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-&#x3b1; mediates C9orf72-related neurodegeneration. Brain. 2018;141:2908&#x2013;2924. doi: 10.1093/brain/awy241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy241</ArticleId><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ognjenovi&#x107;, J. &amp; Simonovi&#x107;, M. Human aminoacyl-tRNA synthetases in diseases of the nervous system. RNA Biol. 15, 623&#x2013;634 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103678</ArticleId><ArticleId IdType="pubmed">28534666</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu. Rev. Genomics Hum. Genet. 2008;9:87&#x2013;107. doi: 10.1146/annurev.genom.9.081307.164204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genom.9.081307.164204</ArticleId><ArticleId IdType="pubmed">18767960</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Schimmel P. Structural analyses clarify the complex control of mistranslation by tRNA synthetases. Curr. Opin. Struct. Biol. 2012;22:119&#x2013;126. doi: 10.1016/j.sbi.2011.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2011.11.008</ArticleId><ArticleId IdType="pmc">PMC3288634</ArticleId><ArticleId IdType="pubmed">22155179</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenke K, et al. FARSA mutations mimic phenylalanyl-tRNA synthetase deficiency caused by FARSB defects. Clin. Genet. 2019;96:468&#x2013;472. doi: 10.1111/cge.13614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13614</ArticleId><ArticleId IdType="pubmed">31355908</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimzadeh P, Rezakhani S, Miryounesi M, Alijanpour S. Neurodegenerative disorder and diffuse brain calcifications due to FARSB mutation in two siblings. Clin. Case Rep. 2022;10:e6195. doi: 10.1002/ccr3.6195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.6195</ArticleId><ArticleId IdType="pmc">PMC9347330</ArticleId><ArticleId IdType="pubmed">35937029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Bergert M, Walther A, Suter B. Double-sieving-defective aminoacyl-tRNA synthetase causes protein mistranslation and affects cellular physiology and development. Nat. Commun. 2014;5:5650. doi: 10.1038/ncomms6650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6650</ArticleId><ArticleId IdType="pmc">PMC4263187</ArticleId><ArticleId IdType="pubmed">25427601</ArticleId></ArticleIdList></Reference><Reference><Citation>Loayza-Puch F, et al. Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature. 2016;530:490&#x2013;494. doi: 10.1038/nature16982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16982</ArticleId><ArticleId IdType="pubmed">26878238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, et al. Multiple click-selective tRNA synthetases expand mammalian cell-specific proteomics. J. Am. Chem. Soc. 2018;140:7046&#x2013;7051. doi: 10.1021/jacs.8b03074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.8b03074</ArticleId><ArticleId IdType="pmc">PMC6598694</ArticleId><ArticleId IdType="pubmed">29775058</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan AA, Rubenstein E. Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome. PLoS ONE. 2013;8:e53785. doi: 10.1371/journal.pone.0053785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0053785</ArticleId><ArticleId IdType="pmc">PMC3556072</ArticleId><ArticleId IdType="pubmed">23372670</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuko A, et al. tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase. Science. 2021;373:1161&#x2013;1166. doi: 10.1126/science.abb3356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3356</ArticleId><ArticleId IdType="pmc">PMC8856733</ArticleId><ArticleId IdType="pubmed">34516840</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaulding EL, et al. The integrated stress response contributes to tRNA synthetase&#x2013;associated peripheral neuropathy. Science. 2021;373:1156&#x2013;1161. doi: 10.1126/science.abb3414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3414</ArticleId><ArticleId IdType="pmc">PMC8908546</ArticleId><ArticleId IdType="pubmed">34516839</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldron AL, Wilcox CE, Francklyn CS, Ebert AM. Knock-down of Histidyl-tRNA Synthetase causes cell cycle arrest and apoptosis of neuronal progenitor cells in vivo. Front. Cell Dev. Biol. 2019;7:67. doi: 10.3389/fcell.2019.00067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00067</ArticleId><ArticleId IdType="pmc">PMC6524715</ArticleId><ArticleId IdType="pubmed">31134197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl Acad. Sci. USA. 2013;110:E4530&#x2013;E4539. doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xf6;er S, Gauthier-Coles G. Amino acid homeostasis in mammalian cells with a focus on amino acid transport. J. Nutr. 2022;152:16&#x2013;28. doi: 10.1093/jn/nxab342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxab342</ArticleId><ArticleId IdType="pmc">PMC8754572</ArticleId><ArticleId IdType="pubmed">34718668</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrak J, et al. D&#xe9;j&#xe0; vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics. 2008;8:1744&#x2013;1749. doi: 10.1002/pmic.200700919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200700919</ArticleId><ArticleId IdType="pubmed">18442176</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield DA, Hardas SS, Lange MLB. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer&#x2019;s disease: many pathways to neurodegeneration. J. Alzheimer&#x2019;s Dis. 2010;20:369&#x2013;393. doi: 10.3233/JAD-2010-1375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1375</ArticleId><ArticleId IdType="pmc">PMC2922983</ArticleId><ArticleId IdType="pubmed">20164570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluever V, et al. Protein lifetimes in aged brains reveal a proteostatic adaptation linking physiological aging to neurodegeneration. Sci. Adv. 2022;8:eabn4437. doi: 10.1126/sciadv.abn4437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abn4437</ArticleId><ArticleId IdType="pmc">PMC9122331</ArticleId><ArticleId IdType="pubmed">35594347</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Pinedo U, et al. Notch signalling in the hippocampus of patients with motor neuron disease. Front. Neurosci. 2019;13:302. doi: 10.3389/fnins.2019.00302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00302</ArticleId><ArticleId IdType="pmc">PMC6460507</ArticleId><ArticleId IdType="pubmed">31024234</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, et al. FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. Acta Neuropathol. 2015;130:525&#x2013;535. doi: 10.1007/s00401-015-1448-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1448-6</ArticleId><ArticleId IdType="pmc">PMC4575383</ArticleId><ArticleId IdType="pubmed">26031661</ArticleId></ArticleIdList></Reference><Reference><Citation>Postina R, et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 2004;113:1456. doi: 10.1172/JCI20864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI20864</ArticleId><ArticleId IdType="pmc">PMC406531</ArticleId><ArticleId IdType="pubmed">15146243</ArticleId></ArticleIdList></Reference><Reference><Citation>Losev Y, et al. Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity. Sci. Rep. 2019;9:2254. doi: 10.1038/s41598-019-39218-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39218-x</ArticleId><ArticleId IdType="pmc">PMC6381127</ArticleId><ArticleId IdType="pubmed">30783169</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez de San Jos&#xe9; N, et al. Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. J. Neural Transm. 2021;129:207&#x2013;230. doi: 10.1007/s00702-021-02411-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-021-02411-2</ArticleId><ArticleId IdType="pmc">PMC8866268</ArticleId><ArticleId IdType="pubmed">34460014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou J, et al. Peroxisomal alterations in Alzheimer&#x2019;s disease. Acta Neuropathol. 2011;122:271&#x2013;283. doi: 10.1007/s00401-011-0836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0836-9</ArticleId><ArticleId IdType="pmc">PMC3168371</ArticleId><ArticleId IdType="pubmed">21594711</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolla CM, Lodhi IJ. Peroxisomal dysfunction in age-related diseases. Trends Endocrinol. Metab. 2017;28:297. doi: 10.1016/j.tem.2016.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2016.12.003</ArticleId><ArticleId IdType="pmc">PMC5366081</ArticleId><ArticleId IdType="pubmed">28063767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellouze S, et al. Golgi fragmentation in pmn mice is due to a defective ARF1/TBCE cross-talk that coordinates COPI vesicle formation and tubulin polymerization. Hum. Mol. Genet. 2014;23:5961&#x2013;5975. doi: 10.1093/hmg/ddu320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu320</ArticleId><ArticleId IdType="pubmed">24951541</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng S, et al. Role of the Golgi apparatus in the blood-brain barrier: Golgi protection may be a targeted therapy for neurological diseases. Mol. Neurobiol. 2017;55:4788&#x2013;4801. doi: 10.1007/s12035-017-0691-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0691-3</ArticleId><ArticleId IdType="pubmed">28730529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, et al. Multiple roles of the stress sensor GCN2 in immune cells. Int. J. Mol. Sci. 2023;24:4285. doi: 10.3390/ijms24054285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054285</ArticleId><ArticleId IdType="pmc">PMC10002013</ArticleId><ArticleId IdType="pubmed">36901714</ArticleId></ArticleIdList></Reference><Reference><Citation>Boczonadi V, Jennings MJ, Horvath R. The role of tRNA synthetases in neurological and neuromuscular disorders. FEBS Lett. 2018;592:703&#x2013;717. doi: 10.1002/1873-3468.12962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12962</ArticleId><ArticleId IdType="pmc">PMC5873386</ArticleId><ArticleId IdType="pubmed">29288497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D, et al. Dysregulation of axonal transport and motorneuron diseases. Biol. Cell. 2011;103:87&#x2013;107. doi: 10.1042/BC20100093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BC20100093</ArticleId><ArticleId IdType="pubmed">21250942</ArticleId></ArticleIdList></Reference><Reference><Citation>Benito I, Casa&#xf1;as JJ, Montesinos ML. Proteomic analysis of synaptoneurosomes highlights the relevant role of local translation in the hippocampus. Proteomics. 2018;18:1800005. doi: 10.1002/pmic.201800005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201800005</ArticleId><ArticleId IdType="pubmed">29923338</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW, Cho BH, Park SG, Kim S. Aminoacyl-tRNA synthetase complexes: beyond translation. J. Cell Sci. 2004;117:3725&#x2013;3734. doi: 10.1242/jcs.01342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01342</ArticleId><ArticleId IdType="pubmed">15286174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lojewski X, et al. Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum. Mol. Genet. 2014;23:2005&#x2013;2022. doi: 10.1093/hmg/ddt596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt596</ArticleId><ArticleId IdType="pmc">PMC3959814</ArticleId><ArticleId IdType="pubmed">24271013</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, et al. C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21&#x2013;linked amyotrophic lateral sclerosis and frontotemporal dementia. Arch. Neurol. 2012;69:1159&#x2013;1163. doi: 10.1001/archneurol.2012.377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2012.377</ArticleId><ArticleId IdType="pubmed">22964911</ArticleId></ArticleIdList></Reference><Reference><Citation>Malnar M, Rogelj B. SFPQ regulates the accumulation of RNA foci and dipeptide repeat proteins from the expanded repeat mutation in C9orf72. J. Cell Sci. 2021;134:jcs256602. doi: 10.1242/jcs.256602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.256602</ArticleId><ArticleId IdType="pmc">PMC7904093</ArticleId><ArticleId IdType="pubmed">33495278</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier O, et al. Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration. Neurochem. Int. 2013;62:1029&#x2013;1038. doi: 10.1016/j.neuint.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.03.008</ArticleId><ArticleId IdType="pubmed">23562846</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;talekar M, et al. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience. 2015;293:157&#x2013;170. doi: 10.1016/j.neuroscience.2015.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.046</ArticleId><ArticleId IdType="pubmed">25743254</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442&#x2013;D450. doi: 10.1093/nar/gky1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1106</ArticleId><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JW, et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature. 2006;443:50&#x2013;55. doi: 10.1038/nature05096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05096</ArticleId><ArticleId IdType="pubmed">16906134</ArticleId></ArticleIdList></Reference><Reference><Citation>Moor N, Linshiz G, Safro M. Cloning and expression of human phenylalanyl-tRNA synthetase in Escherichia coli: comparative study of purified recombinant enzymes. Protein Expr. Purif. 2002;24:260&#x2013;267. doi: 10.1006/prep.2001.1560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/prep.2001.1560</ArticleId><ArticleId IdType="pubmed">11858721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>